O'Donnell Niall has filed 5 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 17500 shares of OnKure Therapeutics, Inc. ($OKUR) on June 06, 2023.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 6, 2023 | OnKure Therapeutics, Inc. | $OKUR | O'Donnell Niall | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| May 25, 2023 | SPRUCE BIOSCIENCES, INC. | $SPRB | O'Donnell Niall | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 16, 2023 | SPRUCE BIOSCIENCES, INC. | $SPRB | O'Donnell Niall | Director | P | Common Stock | 630400 | $3.17 | 1,326,305.0000 | 0 | 90.59% | 0.00% |
| Feb. 16, 2023 | SPRUCE BIOSCIENCES, INC. | $SPRB | O'Donnell Niall | Director | P | Common Stock Warrant (Right to Buy) | 472800 | $0.00 | 472,800.0000 | 0 | 9999.99% | 0.00% |
| May 8, 2023 | OnKure Therapeutics, Inc. | $OKUR | O'Donnell Niall | Director | P | Common Stock | 125000 | $8.00 | 2,188,713.0000 | 0 | 6.06% | 0.00% |